{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:18:12Z","timestamp":1793780292999,"version":"4.6.1"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.mcn.2025.104005","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T13:23:58Z","timestamp":1742563438000},"page":"104005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["GSK-3\u03b2 dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression"],"prefix":"10.1016","volume":"133","author":[{"given":"A.","family":"Rekha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Arockia","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya V.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Supriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti Bedanta","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2025.104005_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111043","article-title":"Vitamin D, calbindin, and calcium signaling: unraveling the Alzheimer\u2019s connection","volume":"116","author":"Acharya","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.mcn.2025.104005_bb0010","article-title":"Natural compound screening predicts novel GSK-3 isoform-specific inhibitors","author":"Ahmad","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.mcn.2025.104005_bb0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41419-022-05153-5","article-title":"ER stress and UPR in Alzheimer\u2019s disease: mechanisms, pathogenesis, treatments","volume":"13","author":"Ajoolabady","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118767","article-title":"GSK-3-associated signaling is crucial to virus infection of cells","volume":"1867","author":"Alfhili","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.mcn.2025.104005_bb0025","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2174\/0929867330666221122115212","article-title":"Role of flavonoids in management of various biological targets in Alzheimer\u2019s disease: evidence from preclinical to clinical studies","volume":"30","author":"Alharbi","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mcn.2025.104005_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/1871527322666230508123558","article-title":"Anaesthesia-induced changes in genomic expression leading to neurodegeneration","volume":"23","author":"Alharbi","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.mcn.2025.104005_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jpi.12238","article-title":"Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3\/Akt\/GSk3\u03b2 pathway in the mouse hippocampus","volume":"59","author":"Ali","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0040","article-title":"Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation","volume":"11","author":"Alquezar","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.mcn.2025.104005_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.595532","article-title":"Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation","volume":"11","author":"Alquezar","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.mcn.2025.104005_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102200","article-title":"GSK-3\u03b2 as a target for apigenin-induced neuroprotection against A\u03b2 25\u201335 in a rat model of Alzheimer\u2019s disease","volume":"90","author":"Alsadat","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mcn.2025.104005_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102058","article-title":"Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation","volume":"24","author":"Amaral","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.mcn.2025.104005_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102058","article-title":"Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3\u03b2) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation","volume":"24","author":"Amaral","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.mcn.2025.104005_bb0065","article-title":"Glycogen synthase Kinase-3 inhibitors: preclinical and clinical focus on CNS-A decade onward","volume":"14","author":"Arciniegas Ruiz","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0070","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.2174\/0929867331666230727103553","article-title":"Aducanumab in Alzheimer\u2019s disease: a critical update","volume":"31","author":"Ashique","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mcn.2025.104005_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","article-title":"Role of tau as a microtubule-associated protein: structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025817","article-title":"Microtubule-based transport and the distribution, tethering, and organization of organelles","volume":"9","author":"Barlan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.mcn.2025.104005_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102689","article-title":"Bridging gap in the treatment of Alzheimer\u2019s disease via postbiotics: current practices and future prospects","volume":"105","author":"Bashir","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2025.104005_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110296","article-title":"Neuropharmacological effect of risperidone: from chemistry to medicine","volume":"369","author":"Bhat","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mcn.2025.104005_bb0095","series-title":"Curcumin-based Nanoformulations as an Emerging Therapeutic Strategy for Inflammatory Lung Diseases","first-page":"583","author":"Bhat","year":"2023"},{"key":"10.1016\/j.mcn.2025.104005_bb0100","series-title":"Synergistic Welfare of Synbiotic Nutraceuticals on Neurological Function. Synbiotics in Human Health: Biology to Drug Delivery","first-page":"571","author":"Bhat","year":"2024"},{"key":"10.1016\/j.mcn.2025.104005_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70053","article-title":"Therapeutic approaches targeting aging and cellular senescence in Huntington\u2019s disease","volume":"30","author":"Bhat","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.mcn.2025.104005_bb0110","article-title":"Nrf2 pathways in neuroprotection: alleviating mitochondrial dysfunction and cognitive impairment in aging","volume":"123056","author":"Bhat","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0115","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2025.104005_bb0120","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1523\/JNEUROSCI.16-11-03601.1996","article-title":"Tau is enriched on dynamic microtubules in the distal region of growing axons","volume":"16","author":"Black","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neuron.2016.09.049","article-title":"Branch-specific microtubule destabilization mediates axon branch loss during neuromuscular synapse elimination","volume":"92","author":"Brill","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2025.104005_bb0130","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-170543","article-title":"Oxidative stress, amyloid-\u03b2 peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer\u2019s disease","volume":"62","author":"Butterfield","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0135","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2353\/ajpath.2007.061178","article-title":"Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles","volume":"170","author":"Caccamo","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2025.104005_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106726","article-title":"Early dysregulation of GSK3\u03b2 impairs mitochondrial activity in Fragile X Syndrome","volume":"203","author":"Cencelli","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.mcn.2025.104005_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12989","article-title":"Aging-induced Akt activation involves in aging-related pathologies and A\u03b2-induced toxicity","volume":"18","author":"Chen","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.mcn.2025.104005_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.freeradbiomed.2023.09.004","article-title":"TFEB regulates cellular labile iron and prevents ferroptosis in a TfR1-dependent manner","volume":"208","author":"Chen","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mcn.2025.104005_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154887","article-title":"Quercetin: a promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis","volume":"126","author":"Cheng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mcn.2025.104005_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fnbeh.2015.00158","article-title":"Lentiviral silencing of GSK-3\u03b2 in adult dentate gyrus impairs contextual fear memory and synaptic plasticity","volume":"9","author":"Chew","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","article-title":"Cellular and pathological heterogeneity of primary tauopathies","volume":"16","author":"Chung","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcn.2025.104005_bb0175","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mcn.2025.104005_bb0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2011.09.002","article-title":"Activation of glycogen synthase kinase-3 beta mediates \u03b2-amyloid induced neuritic damage in Alzheimer\u2019s disease","volume":"45","author":"DaRocha-Souto","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acs.jmedchem.0c00931","article-title":"Glycogen synthase kinase 3\u03b2: a new gold rush in anti-Alzheimer\u2019s disease multitarget drug discovery?","volume":"64","author":"De Simone","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mcn.2025.104005_bb0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14728222.2018.1486823","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?","volume":"22","author":"Deming","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.mcn.2025.104005_bb0195","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jnc.13351","article-title":"Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3\u03b2 signaling pathway","volume":"135","author":"Deng","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2025.104005_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcn.2025.104005_bb0205","first-page":"595","article-title":"The role of tau kinases in Alzheimer\u2019s disease","volume":"13","author":"Dolan","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.mcn.2025.104005_bb0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbior.2018.06.001","article-title":"Systematic analysis of GSK-3 signaling pathways in aging of cerebral tissue","volume":"69","author":"Drulis-Fajdasz","year":"2018","journal-title":"Advances in biological regulation"},{"key":"10.1016\/j.mcn.2025.104005_bb0215","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson\u2019s disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.mcn.2025.104005_bb0220","doi-asserted-by":"crossref","first-page":"25959","DOI":"10.3390\/ijms161125939","article-title":"Energy metabolism of the brain, including the cooperation between astrocytes and neurons, especially in the context of glycogen metabolism","volume":"16","author":"Falkowska","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-002-0587-8","article-title":"Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer\u2019s disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration","volume":"104","author":"Ferrer","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2025.104005_bb0230","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2009.08121873","article-title":"Roles of the Akt\/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action","volume":"167","author":"Freyberg","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.mcn.2025.104005_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102033","article-title":"The neurobiology and therapeutic potential of multi-targeting \u03b2-secretase, glycogen synthase kinase 3\u03b2 and acetylcholinesterase in Alzheimer\u2019s disease","volume":"90","author":"Fronza","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2025.104005_bb0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/ADR-180087","article-title":"Effects of thioflavin T and GSK-3 inhibition on lifespan and motility in a Caenorhabditis elegans model of tauopathy","volume":"3","author":"Gamir-Morralla","year":"2019","journal-title":"Journal of Alzheimer\u2019s disease reports"},{"key":"10.1016\/j.mcn.2025.104005_bb0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12116","article-title":"Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3\u03b2 pathway in streptozotocin-induced Alzheimer rat model","volume":"24","author":"Gao","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.mcn.2025.104005_bb0250","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ddr.21515","article-title":"Structure-activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition","volume":"80","author":"Gao","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0255","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-2008-14407","article-title":"Truncation of tau protein and its pathological significance in Alzheimer\u2019s disease","volume":"14","author":"Garc\u00eda-Sierra","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcn.2025.104005_bb0265","doi-asserted-by":"crossref","first-page":"22406","DOI":"10.1074\/jbc.M702793200","article-title":"N-terminal cleavage of GSK-3 by Calpain: a NEW FORM OF GSK-3 REGULATION*","volume":"282","author":"Go\u00f1i-Oliver","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2025.104005_bb0270","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuroscience.2004.12.029","article-title":"Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes","volume":"132","author":"Goodenough","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2025.104005_bb0275","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1980-57642009DN30100002","article-title":"Argyrophilic grain disease: an update about a frequent cause of dementia","volume":"3","author":"Grinberg","year":"2009","journal-title":"Dementia & neuropsychologia"},{"key":"10.1016\/j.mcn.2025.104005_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107300","article-title":"PI3K\/AKT signaling pathway: molecular mechanisms and therapeutic potential in depression","volume":"206","author":"Guo","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0285","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.mcn.2025.104005_bb0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-405210-9.00004-7","article-title":"Kinase-kinase interaction and modulation of tau phosphorylation","volume":"300","author":"Hashiguchi","year":"2013","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.mcn.2025.104005_bb0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/1673-5374.313016","article-title":"Presenilin mutations and their impact on neuronal differentiation in Alzheimer\u2019s disease","volume":"17","author":"Hernandez-Sapiens","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040820","article-title":"GSK3: a kinase balancing promotion and resolution of inflammation","volume":"9","author":"Hoffmeister","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.mcn.2025.104005_bb0305","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neurobiolaging.2013.08.032","article-title":"Interactions between GSK3\u03b2 and amyloid genes explain variance in amyloid burden","volume":"35","author":"Hohman","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2025.104005_bb0310","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2025.104005_bb0315","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2025.104005_bb0320","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1471-4159.2008.05483.x","article-title":"Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells","volume":"106","author":"Hu","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2025.104005_bb0325","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/10799893.2013.848891","article-title":"Curcumin attenuates amyloid-\u03b2-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN\/Akt\/GSK-3\u03b2 signaling pathway","volume":"34","author":"Huang","year":"2014","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.mcn.2025.104005_bb0330","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040248","article-title":"Adult-onset neuronal ceroid lipofuscinosis misdiagnosed as autoimmune encephalitis and normal-pressure hydrocephalus: a 10-year case report and case-based review","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mcn.2025.104005_bb0335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0340","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41698-018-0049-y","article-title":"Interaction between Wnt\/\u03b2-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of \u03b2-catenin and RAS by targeting the Wnt\/\u03b2-catenin pathway","volume":"2","author":"Jeong","year":"2018","journal-title":"npj Precision Oncology"},{"key":"10.1016\/j.mcn.2025.104005_bb0350","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.omtn.2022.04.008","article-title":"miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways","volume":"28","author":"Jiang","year":"2022","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"10.1016\/j.mcn.2025.104005_bb0355","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1038\/srep08187","article-title":"Truncation and activation of GSK-3\u03b2 by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer\u2019s disease","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcn.2025.104005_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101500","article-title":"Navigating the GSK-3\u03b2 inhibitors as versatile multi-target drug ligands in Alzheimer\u2019s disease intervention \u2013 a comprehensive review","volume":"7","author":"Jitendra Joshi","year":"2024","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.mcn.2025.104005_bb0365","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives","volume":"11","author":"Jurc\u0103u","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.mcn.2025.104005_bb0370","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1073\/pnas.1504081112","article-title":"Tau stabilizes microtubules by binding at the interface between tubulin heterodimers","volume":"112","author":"Kadavath","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mcn.2025.104005_bb0375","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11030-018-9839-y","article-title":"Structure\u2013activity relationship investigation of coumarin\u2013chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"22","author":"Kang","year":"2018","journal-title":"Mol. Divers."},{"key":"10.1016\/j.mcn.2025.104005_bb0380","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/0118715273321002240919102841","article-title":"Exploring therapeutic strategies: the relationship between metabolic disorders and FOXO Signalling in Alzheimer\u2019s disease","volume":"24","author":"Kaur","year":"2025","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.mcn.2025.104005_bb0385","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2009.05088.x","article-title":"Extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling in cardiac hypertrophy","volume":"1188","author":"Kehat","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158263","article-title":"GSK3-driven modulation of inflammation and tissue integrity in the animal model","volume":"25","author":"K\u00fchl","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0395","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.21476","article-title":"Glycogen synthase kinase-3beta and tau genes interact in Alzheimer\u2019s disease","volume":"64","author":"Kwok","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2025.104005_bb0400","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.21476","article-title":"Glycogen synthase kinase-3\u03b2 and tau genes interact in Alzheimer\u2019s disease","volume":"64","author":"Kwok","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2025.104005_bb0405","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16635","article-title":"New insights into the role of GSK-3\u03b2 in the brain: from neurodegenerative disease to tumorigenesis","volume":"11","author":"Lai","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.mcn.2025.104005_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/j.mcn.2025.104005_bb0415","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.18632\/aging.205295","article-title":"Gypenoside IX restores Akt\/GSK-3\u03b2 pathway and alleviates Alzheimer\u2019s disease-like neuropathology and cognitive deficits","volume":"15","author":"Lei","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.mcn.2025.104005_bb0420","doi-asserted-by":"crossref","first-page":"e2206","DOI":"10.1038\/cddis.2016.104","article-title":"GSK-3\u03b2-induced Tau pathology drives hippocampal neuronal cell death in Huntington\u2019s disease: involvement of astrocyte\u2013neuron interactions","volume":"7","author":"L\u2019Episcopo","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK-3\u03b2 in Alzheimer\u2019s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration","volume":"33","author":"Leroy","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.mcn.2025.104005_bb0430","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2025.104005_bb0435","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1002\/jcb.28276","article-title":"miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3\u03b2 in Alzheimer\u2019s disease","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mcn.2025.104005_bb0440","article-title":"Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an a\u03b2(25-35)-induced rat model of Alzheimer\u2019s disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mcn.2025.104005_bb0445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s41983-023-00751-2","article-title":"Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta inhibition","volume":"59","author":"Limantoro","year":"2023","journal-title":"The Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"key":"10.1016\/j.mcn.2025.104005_bb0450","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3233\/JAD-2012-111898","article-title":"Bip enhanced the association of GSK-3\u03b2 with tau during ER stress both in vivo and in vitro","volume":"29","author":"Liu","year":"2012","journal-title":"Journal of Alzheimer\u2019s disease\u202f: JAD"},{"key":"10.1016\/j.mcn.2025.104005_bb0455","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arr.2016.11.006","article-title":"Aging of cerebral white matter","volume":"34","author":"Liu","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2025.104005_bb0460","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0465","first-page":"196","article-title":"Communication networks in the brain: neurons, receptors, neurotransmitters, and alcohol","volume":"31","author":"Lovinger","year":"2008","journal-title":"Alcohol research & health\u202f: the journal of the National Institute on Alcohol Abuse and Alcoholism"},{"key":"10.1016\/j.mcn.2025.104005_bb0470","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ddr.21726","article-title":"Nitrogen-containing flavonoid and their analogs with diverse B-ring in acetylcholinesterase and butyrylcholinesterase inhibition","volume":"81","author":"Lu","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0475","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear \u03b2-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3\u03b2 conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.mcn.2025.104005_bb0480","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11515-012-1222-2","article-title":"The role of GSK3beta in the development of the central nervous system","volume":"7","author":"Luo","year":"2012","journal-title":"Front. Biol."},{"key":"10.1016\/j.mcn.2025.104005_bb0485","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fphar.2019.00395","article-title":"Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mcn.2025.104005_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102578","article-title":"Non-canonical pathways associated to amyloid beta and tau protein dyshomeostasis in Alzheimer\u2019s disease: a narrative review","volume":"102","author":"Maggiore","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2025.104005_bb0495","first-page":"001","article-title":"The role of glycogen synthase kinase 3 Beta in neuroinflammation and pain","volume":"1","author":"Maixner","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.mcn.2025.104005_bb0500","first-page":"19","article-title":"Wnt\/\u03b2-catenin signaling pathway governs a full program for dopaminergic neuron survival, neurorescue and regeneration in the MPTP mouse model of Parkinson\u2019s disease","author":"Marchetti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0505","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/leu.2013.184","article-title":"Multifaceted roles of GSK-3 and Wnt\/\u03b2-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention","volume":"28","author":"McCubrey","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.mcn.2025.104005_bb0510","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbior.2017.05.005","article-title":"Regulation of GSK-3 activity by curcumin, berberine and resveratrol: potential effects on multiple diseases","volume":"65","author":"McCubrey","year":"2017","journal-title":"Advances in biological regulation"},{"key":"10.1016\/j.mcn.2025.104005_bb0515","series-title":"The Role of Mitochondrial Dysfunction and Oxidative Stress in Age-dependent Neurodegeneration: Implications for the Use of Mitochondria-targeted Therapeutics","author":"McManus","year":"2010"},{"key":"10.1016\/j.mcn.2025.104005_bb0520","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091126","article-title":"Alzheimer\u2019s disease: a molecular view of \u03b2-amyloid induced morbific events","volume":"9","author":"Mohamed Asik","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.mcn.2025.104005_bb0530","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"Journal of Alzheimer\u2019s disease\u202f: JAD"},{"key":"10.1016\/j.mcn.2025.104005_bb0535","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0035-3787(06)75098-6","article-title":"Transgenic mouse models for Alzheimer\u2019s disease: the role of GSK-3\u03b2 in combined amyloid and tau-pathology","volume":"162","author":"Muyllaert","year":"2006","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.mcn.2025.104005_bb0540","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1601-183X.2007.00376.x","article-title":"Glycogen synthase kinase-3\u03b2, or a link between amyloid and tau pathology?","volume":"7","author":"Muyllaert","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.mcn.2025.104005_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17568919.2024.2421158","article-title":"Synthesis, DFT, ADMET and molecular docking studies of thiazole derived thiazolidinone-based chalcone derivatives: alzheimer\u2019s disease current therapies","author":"Nadeem","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.mcn.2025.104005_bb0550","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.mcn.2025.104005_bb0555","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.18632\/aging.100853","article-title":"Age-related neuroinflammation and changes in AKT-GSK-3\u03b2 and WNT\/ \u03b2-CATENIN signaling in rat hippocampus","volume":"7","author":"Orellana","year":"2015","journal-title":"Aging"},{"key":"10.1016\/j.mcn.2025.104005_bb0560","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/db12-0187","article-title":"Deregulation of protein phosphatase 2A and hyperphosphorylation of \u03c4 protein following onset of diabetes in NOD mice","volume":"62","author":"Papon","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mcn.2025.104005_bb0565","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1038\/cddis.2013.503","article-title":"Oligomeric amyloid \u03b2 induces IL-1\u03b2 processing via production of ROS: implication in Alzheimer\u2019s disease","volume":"4","author":"Parajuli","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mcn.2025.104005_bb0570","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","article-title":"Distribution of active glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) in brains staged for Alzheimer disease neurofibrillary changes","volume":"58","author":"Pei","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2025.104005_bb0575","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1007\/s12035-023-03217-x","article-title":"TREM2 inhibits tau hyperphosphorylation and neuronal apoptosis via the PI3K\/Akt\/GSK-3\u03b2 signaling pathway in vivo and in vitro","volume":"60","author":"Peng","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2025.104005_bb0580","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ddr.10100","article-title":"Role of GSK-3\u03b2 in Alzheimer\u2019s disease pathology","volume":"56","author":"Planel","year":"2002","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0585","first-page":"51","article-title":"Arctigenin attenuates learning and memory deficits through PI3k\/Akt\/GSK-3\u03b2 pathway reducing tau hyperphosphorylation in A\u03b2-induced AD mice","volume":"83","author":"Qi","year":"2017","journal-title":"Planta Med."},{"key":"10.1016\/j.mcn.2025.104005_bb0590","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.2174\/1568026618666180112161406","article-title":"Dual BACE-1\/GSK-3\u03b2 inhibitors to combat Alzheimer\u2019s disease: a focused review","volume":"17","author":"Rampa","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.mcn.2025.104005_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpnec.2020.100019","article-title":"Differential activation of Gsk-3\u03b2 in the cortex and the hippocampus induces cognitive and behavioural impairments in middle-aged ovariectomized rat","volume":"4","author":"Rana","year":"2020","journal-title":"Comprehensive Psychoneuroendocrinology"},{"key":"10.1016\/j.mcn.2025.104005_bb0600","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1326-2-12","article-title":"Tau phosphorylation by GSK-3\u03b2 promotes tangle-like filament morphology","volume":"2","author":"Rankin","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcn.2025.104005_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0610","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.bbadis.2013.06.012","article-title":"Amyloid beta-induced glycogen synthase kinase 3\u03b2 phosphorylated VDAC1 in Alzheimer\u2019s disease: implications for synaptic dysfunction and neuronal damage","volume":"1832","author":"Reddy","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2025.104005_bb0615","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1478-811X-7-20","article-title":"Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation","volume":"7","author":"Resende","year":"2009","journal-title":"Cell communication and signaling\u202f: CCS"},{"key":"10.1016\/j.mcn.2025.104005_bb0620","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jnr.21648","article-title":"ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation","volume":"86","author":"Resende","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0625","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jnr.21648","article-title":"ER stress is involved in A\u03b2-induced GSK-3\u03b2 activation and tau phosphorylation","volume":"86","author":"Resende","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0630","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.neurobiolaging.2013.03.015","article-title":"Tau phosphorylation affects its axonal transport and degradation","volume":"34","author":"Rodr\u00edguez-Mart\u00edn","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2025.104005_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.561470","article-title":"Overexpression of GSK-3\u03b2 in adult Tet-OFF GSK-3\u03b2 transgenic mice, and not during embryonic or postnatal development, induces tau phosphorylation, neurodegeneration and learning deficits","volume":"13","author":"Rodr\u00edguez-Matell\u00e1n","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2006.12.001","article-title":"Regulation of intrinsic neuronal properties for axon growth and regeneration","volume":"81","author":"Rossi","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mcn.2025.104005_bb0645","first-page":"20","article-title":"The therapeutic potential of apigenin","author":"Salehi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0650","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","article-title":"Advanced glycation end products in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"153","author":"Sasaki","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2025.104005_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040721","article-title":"GSK-3 and tau: a key duet in Alzheimer\u2019s disease","volume":"10","author":"Sayas","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mcn.2025.104005_bb0660","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/cells10040721","article-title":"GSK-3 and tau: a key duet in Alzheimer\u2019s disease","volume":"10","author":"Sayas","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mcn.2025.104005_bb0665","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Current biology\u202f: CB"},{"key":"10.1016\/j.mcn.2025.104005_bb0670","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","article-title":"Biomarkers for tau pathology","volume":"97","author":"Sch\u00f6ll","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0675","doi-asserted-by":"crossref","first-page":"688","DOI":"10.34172\/apb.2023.071","article-title":"Role of GSK-3\u03b2 inhibitors: new promises and opportunities for Alzheimer\u2019s disease","volume":"13","author":"Shri","year":"2023","journal-title":"Advanced pharmaceutical bulletin"},{"key":"10.1016\/j.mcn.2025.104005_bb0680","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020255","article-title":"Lithium and therapeutic targeting of GSK-3","volume":"10","author":"Snitow","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mcn.2025.104005_bb0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001087","article-title":"Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer\u2019s disease","volume":"6","author":"Sofola","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mcn.2025.104005_bb0690","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4161\/cc.27728","article-title":"Inhibition of GSK-3\u03b2 activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells","volume":"13","author":"Sokolosky","year":"2014","journal-title":"Cell cycle (Georgetown, Tex)"},{"key":"10.1016\/j.mcn.2025.104005_bb0695","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/156720512800107618","article-title":"The role of ER stress-induced apoptosis in neurodegeneration","volume":"9","author":"Stefani","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0700","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12035-014-9063-4","article-title":"The ubiquitin-proteasome system and molecular chaperone deregulation in Alzheimer\u2019s disease","volume":"53","author":"Sulistio","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2025.104005_bb0705","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1142\/S0192415X17500902","article-title":"Curcumin decreases hyperphosphorylation of tau by down-regulating caveolin-1\/GSK-3\u03b2 in N2a\/APP695swe cells and APP\/PS1 double transgenic Alzheimer\u2019s disease mice","volume":"45","author":"Sun","year":"2017","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.mcn.2025.104005_bb0710","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mcn.2025.104005_bb0715","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","article-title":"Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice","volume":"172","author":"Terwel","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2025.104005_bb0720","first-page":"595","article-title":"Recent developments in the role of protocatechuic acid in neurodegenerative disorders","volume":"22","author":"Thapa","year":"2023","journal-title":"EXCLI J."},{"key":"10.1016\/j.mcn.2025.104005_bb0725","article-title":"A review of glycogen synthase kinase-3 (GSK3) inhibitors for cancers therapies","volume":"127375","author":"Thapa","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mcn.2025.104005_bb0730","article-title":"Proteostasis disruption and senescence in Alzheimer\u2019s disease pathways to neurodegeneration","volume":"149202","author":"Thapa","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2025.104005_bb0735","article-title":"The role of sirtuin 1 in ageing and neurodegenerative disease: a molecular perspective","volume":"102545","author":"Thapa","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2025.104005_bb0740","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fncel.2020.00019","article-title":"GSK3\u03b2 and tau protein in Alzheimer\u2019s disease and epilepsy","volume":"14","author":"Toral-Rios","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.mcn.2025.104005_bb0745","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1007\/s12035-024-04003-z","article-title":"Therapeutic potential effect of glycogen synthase kinase 3 Beta (GSK-3\u03b2) inhibitors in Parkinson disease: exploring an overlooked avenue","volume":"61","author":"Turkistani","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2025.104005_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145030","article-title":"Tau and alpha synuclein synergistic effect in neurodegenerative diseases: when the periphery is the core","volume":"21","author":"Vacchi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104005_bb0755","doi-asserted-by":"crossref","first-page":"26551","DOI":"10.1021\/acsomega.0c03302","article-title":"Machine learning for discovery of GSK3\u03b2 inhibitors","volume":"5","author":"Vignaux","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.mcn.2025.104005_bb0760","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2174\/0115680266296001240327090111","article-title":"Neuroprotective role of phytoconstituents-based nanoemulsion for the treatment of Alzheimer\u2019s disease","volume":"24","author":"Vishwas","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.mcn.2025.104005_bb0765","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neurobiolaging.2014.07.035","article-title":"Cross talk between PI3K-AKT-GSK-3\u03b2 and PP2A pathways determines tau hyperphosphorylation","volume":"36","author":"Wang","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2025.104005_bb0770","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1039\/C9NR01255A","article-title":"Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT\/GSK-3\u03b2 pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.mcn.2025.104005_bb0775","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/med.21867","article-title":"Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases","volume":"42","author":"Wang","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.mcn.2025.104005_bb0780","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.18632\/aging.102303","article-title":"GSK-3\u03b2 and ERK1\/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats","volume":"11","author":"Wei","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.mcn.2025.104005_bb0785","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/alz.12901","article-title":"The worldwide costs of dementia in 2019","volume":"19","author":"Wimo","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.mcn.2025.104005_bb0790","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12802","article-title":"Aging and Alzheimer\u2019s disease: comparison and associations from molecular to system level","volume":"17","author":"Xia","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.mcn.2025.104005_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117186","article-title":"Saponins derived from Gynostemma pentaphyllum regulate triglyceride and cholesterol metabolism and the mechanisms: a review","volume":"319","author":"Xie","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mcn.2025.104005_bb0800","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"Journal of central nervous system disease"},{"key":"10.1016\/j.mcn.2025.104005_bb0805","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1039\/C4CS00038B","article-title":"O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer\u2019s disease and beyond","volume":"43","author":"Yuzwa","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mcn.2025.104005_bb0810","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40035-016-0068-y","article-title":"Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3\u03b2 phosphorylation in a tau transgenic Drosophila model of Alzheimer\u2019s disease","volume":"5","author":"Zhang","year":"2016","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.mcn.2025.104005_bb0815","article-title":"Neuroprotective effects of salidroside in the MPTP mouse model of Parkinson\u2019s disease: involvement of the PI3K\/Akt\/GSK3\u03b2 pathway","volume":"2016","author":"Zhang","year":"2016","journal-title":"Parkinson\u2019s disease"},{"key":"10.1016\/j.mcn.2025.104005_bb0820","article-title":"Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction","volume":"10","author":"Zhang","year":"2022","journal-title":"Frontiers in cell and developmental biology"},{"key":"10.1016\/j.mcn.2025.104005_bb0825","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.mcn.2025.104005_bb0830","doi-asserted-by":"crossref","first-page":"33032","DOI":"10.1021\/acsnano.4c05693","article-title":"Multi targeted therapy for Alzheimer\u2019s disease by guanidinium-modified calixarene and cyclodextrin co-assembly loaded with insulin","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mcn.2025.104005_bb0835","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14818","article-title":"GSK3: a potential target and pending issues for treatment of Alzheimer\u2019s disease","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.mcn.2025.104005_bb0840","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13205-021-02738-3","article-title":"Role of insulin receptor substance-1 modulating PI3K\/Akt insulin signaling pathway in Alzheimer\u2019s disease","volume":"11","author":"Zheng","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.mcn.2025.104005_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103970","article-title":"Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration","volume":"78","author":"Zhou","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.mcn.2025.104005_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103970","article-title":"Human tau accumulation promotes glycogen synthase kinase-3\u03b2 acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration","volume":"78","author":"Zhou","year":"2022","journal-title":"eBioMedicine"}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743125000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743125000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:31:08Z","timestamp":1749184268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743125000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":170,"alternative-id":["S1044743125000156"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2025.104005","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK-3\u03b2 dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2025.104005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104005"}}